Please login to the form below

Not currently logged in
Email:
Password:

Immuno-oncology's evolution: impacts for pharma market researchers
Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.

Over the past 12 months several new products have been approved for a wider range of tumour types and with pipelines boasting numerous other products in the area, competition looks set to hot up.

On November 17 Research Partnership, in association with PMGroup, will host a free webinar which will explore the key features of the immuno-oncology market and the critical success factors for remaining competitive.

Key areas that will be discussed include: 

Setting the context
The current situation in immuno-oncology and challenges and opportunities for new targeted therapies entering the market.

Portfolio Panning
Understanding where to invest in the early stages of new product development in order to achieve your objectives.

Marketing and communications
Considerations for the positioning and marketing communications strategy with regards to the evolution of each indication. How this will impact your market research needs.

Biomarker strategies
The impact of biomarker availability on patient selection and sequencing. How to ensure your biomarker strategies are optimised for your brand.

If you have any further comments or questions regarding today’s webinar or would like to know more about our experience in immuno-oncology research, please visit www.researchpartnership.com

 

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics